{"entity":{"id":"nct06819215","kind":"trial","name":"Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors","aka":[],"tldr":"This study tests a PARP inhibitor; the registry reports that it is recruiting.","summary":"The registry lists NCT06819215 as recruiting, last updated 2025-02-11. Enrolment is 188 planned participants, an estimate. Interventions: VB15010. Primary measures include The number of subjects with adverse events/serious adverse events; The number of subjects with dose-limiting toxicity (DLT), as defined in the protocol.. No results are posted in the registry; this does not exclude separate publications.","status":"recruiting","asOf":"2026-10-06","links":[{"label":"ClinicalTrials.gov NCT06819215","url":"https://clinicaltrials.gov/study/NCT06819215"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["ovarian","prostate","pancreatic","cholangiocarcinoma","colorectal"],"sections":[],"technologies":[],"targets":["parp"],"drugs":["vb15010"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06819215","phase":"1/2","setting":"Phase I/II Clinical Study To Evaluate The Safety, Tolerability, Pharmacokinetics, Pharmacodynamics And Preliminary Efficacy of VB15010 Tablets In Patients With Advanced Solid Tumors","sponsor":"Zhejiang Yangli Pharmaceutical Technology Co., Ltd.","participation":[{"nct":"NCT06819215","source":"https://clinicaltrials.gov/study/NCT06819215","fetchedAt":"2026-10-07T16:55:06.589Z","studySha256":"e7b5c60c58daf88c90ddbec37ac0e20e898fdca9739c38dd8ccb7a6dd44c2524","overallStatus":"RECRUITING","lastUpdatePosted":"2025-02-11","leadSponsor":"Zhejiang Yangli Pharmaceutical Technology Co., Ltd.","collaboratorCount":1,"minimumAge":"18 Years","maximumAge":"75 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":188,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["China"]}],"started":"2024-10-30","startedType":"actual","enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06819215/","neighbours":{"cancer":[{"id":"cholangiocarcinoma","kind":"cancer","name":"Biliary tract cancer (cholangiocarcinoma)","route":"/cancers/cholangiocarcinoma/"},{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"ovarian","kind":"cancer","name":"Ovarian cancer","route":"/cancers/ovarian/"},{"id":"pancreatic","kind":"cancer","name":"Pancreatic ductal adenocarcinoma","route":"/cancers/pancreatic/"},{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"target":[{"id":"parp","kind":"target","name":"PARP","route":"/targets/parp/"}],"drug":[{"id":"vb15010","kind":"drug","name":"VB15010","route":"/drugs/vb15010/"}]}}